These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 520477)

  • 1. Modification by levo-propranolol of tremors induced by harmine in mice.
    Kulkarni SK; Kaul PN
    Experientia; 1979 Dec; 35(12):1627-8. PubMed ID: 520477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system.
    Shukla VK; Garg SK; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):50-7. PubMed ID: 3490237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of serotonergic and adrenergic receptor antagonist on prolactin release in the monkey.
    Gala RR; Subramanian MG; Peters JA; Pieper DR
    Life Sci; 1977 Feb; 20(4):631-7. PubMed ID: 14291
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol.
    Alkondon M; Ray A; Sen P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):161-7. PubMed ID: 2865935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.
    Huidobro-Toro JP; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1975; 3(2):235-42. PubMed ID: 238221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone.
    Hwang EC; van Woert MH
    Pharmacol Biochem Behav; 1979 Jan; 10(1):27-9. PubMed ID: 312503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice.
    Kawanishi K; Hashimoto Y; Fujiwara M; Kataoka Y; Ueki S
    J Pharmacobiodyn; 1981 Jul; 4(7):520-7. PubMed ID: 6975366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the tremorgenic actions of harmine in the rat.
    Cox B; Potkonjak D
    Eur J Pharmacol; 1971 Sep; 16(1):39-45. PubMed ID: 4945584
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of metoprolol, practolol, and propranolol after isoprenaline injections in asthmatic patients (author's transl)].
    Svedmyr N; Thiringer G
    Sem Hop; 1980 Apr 18-25; 56(15-16):798-804. PubMed ID: 6246620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation of alcohol withdrawal-induced inhibition of exploratory behaviour and supersensitivity to harmine-induced tremor.
    Meert TF
    Alcohol Alcohol; 1994 Jan; 29(1):91-102. PubMed ID: 7911667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
    Tachikawa S; Takenaka T; Maeno H
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol.
    Gothóni P
    Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):40-6. PubMed ID: 3876687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amphetamine on plasma corticosterone in the conscious rat.
    Knych ET; Eisenberg RM
    Neuroendocrinology; 1979; 29(2):110-8. PubMed ID: 503280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia.
    Fink GD; Paulo LG; Fisher JW
    J Pharmacol Exp Ther; 1975 Apr; 193(1):176-81. PubMed ID: 237111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.
    Stocco MR; Tolledo C; Wadji FB; Gonzalez FJ; Miksys S; Tyndale RF
    Mol Neurobiol; 2020 Nov; 57(11):4608-4621. PubMed ID: 32761352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta-adrenoceptor blocking properties of the alpha-methyl analogues of propranolol and practolol in the anaesthetized dog.
    Levy B
    Br J Pharmacol; 1973 Nov; 49(3):514-26. PubMed ID: 4777711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice.
    Shuto H; Kataoka Y; Kanaya A; Matsunaga K; Sueyasu M; Oishi R
    Eur J Pharmacol; 1998 Jan; 341(1):33-7. PubMed ID: 9489853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of beta-adrenoceptor antagonists on the response to isoprenaline in the oestrogen dominated rabbit uterus.
    Nesheim BI
    Br J Pharmacol; 1975 Mar; 53(3):393-401. PubMed ID: 236797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of extrapyramidal function for the induction and antagonism of harmine tremor.
    Kelly DM; Naylor RJ
    Eur J Pharmacol; 1975 May; 32(1):76-86. PubMed ID: 1149829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and beta-adrenergic antagonist activity of stereoisomeric practolol and propranolol derivatives.
    Leftheris K; Goodman M
    J Med Chem; 1990 Jan; 33(1):216-23. PubMed ID: 1967313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.